AI Terminal
Smiths Group PLC
Share Issue/Capital Change • Mar 1, 2024
4613_rns_2024-03-01_9424f43d-56e6-45ee-8028-908d88a748d3.html
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 0667F
Smiths Group PLC
01 March 2024
1 MARCH 2024
SMITHS GROUP PLC ('Smiths')
SMITHS GROUP PLC SELLS 830,000 SHARES IN ICU MEDICAL INC
Smiths Group plc confirms that it has sold 830,000 shares in ICU Medical Inc ('ICU Medical'), representing approximately 3.44% of ICU Medical's issued share capital, and equivalent to approximately 33% of Smiths' holding in ICU Medical. Smiths will receive net proceeds of c.$88.0m (£69.7m) from the sale which will be used for general corporate purposes.
Smiths continues to hold 1,670,000 shares in ICU Medical representing approximately 6.92% of ICU Medical's issued share capital.
Enquiries:
| Investor enquiries | Media enquiries |
| Siobhán Andrews, Smiths Group +44 (0)7920 230093 [email protected] |
Tom Steiner, Smiths Group +44 (0)7787 415 891 [email protected] |
| Matthew Whyte Company Secretary +44 (0) 7775 982 879 [email protected] |
Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11
About Smiths Group
For over 170 years, Smiths Group has been pioneering progress by improving our world through smarter engineering. We serve millions of people every year, to help create a safer, more efficient, and better-connected world, across four major global markets: Energy, General Industry, Safety & Security and Aerospace. Listed on the London Stock Exchange, Smiths employs more than 15,000 colleagues in over 50 countries. For more information visit www.smiths.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DISSEIEFUELSEIE